The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online 9 December 2002 doi:10.1084/jem.20021515
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 152K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leslie, D. S.
Right arrow Articles by Brenner, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leslie, D. S.
Right arrow Articles by Brenner, M. B.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© Rockefeller University Press, 0022-1007/2002/12/1575/ $5.00
The Journal of Experimental Medicine, Volume 196, Number 12, December 16, 2002 1575-1584

CD1-mediated {gamma}/{delta} T Cell Maturation of Dendritic Cells

David S. Leslie1, Michael S. Vincent1, Franca M. Spada2, Hiranmoy Das1, Masahiko Sugita1, Craig T. Morita3 and Michael B. Brenner1

1 Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital at Harvard Medical School, Boston, MA 02115
2 Mohave Therapeutics, Hawthorne, NY 10532
3 Division of Rheumatology, Department of Internal Medicine, and the Interdisciplinary Group on Immunology, University of Iowa, Iowa City, IA 52242

Address correspondence to Michael B. Brenner, Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, 1 Jimmy Fund Way, Boston, MA 02115. Phone: 617-525-1000; Fax: 617-525-1010; E-mail: mbrenner{at}rics.bwh.harvard.edu

Immature myeloid dendritic cells (DCs) express only low levels of major histocompatibility complex (MHC) class II but express high levels of CD1 a, b, and c antigen-presenting molecules at the cell surface. As V{delta}1+ {gamma}/{delta} T cells are the main tissue subset of {gamma}/{delta} T cells and they are known to recognize CD1c in the absence of specific foreign antigen recognition, we examined the possible interaction of these T cells with immature DCs. We show that CD1-restricted {gamma}/{delta} T cells can mediate the maturation of DCs. DC maturation required cell–cell contact and could be blocked by antibodies against CD1c. The maturation process was partially mediated by tumor necrosis factor {alpha}. Importantly, immature DCs matured in the presence of lipopolysaccharide and CD1-restricted {gamma}/{delta} T cells produced bioactive interleukin-12p70. In addition, these DCs were able to efficiently present peptide antigens to naive CD4+ T cells. CD1-restricted {gamma}/{delta} T cell recognition of immature DCs provides the human immune system with the capacity to rapidly generate a pool of mature DCs early during microbial invasion. This may be an important source of critical host signals for T helper type 1 polarization of antigen-specific naive T cells and the subsequent adaptive immune response.

Key Words: T cell antigen receptors {gamma}/{delta} • CD1 • dendritic cells • antigen-presenting cell • tumor necrosis factor


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS